| 1 |
Basic Science (Anatomy, physiology, pharmacology, behaviour) |
| 1.1 | Primary afferents |
| 1.2 | Spinal cord |
| 1.3 | Brainstem, thalamus, and cortex |
| 1.4 | Gene expression |
| 1.5 | Peripheral sensitization |
| 1.6 | Central sensitization |
| 1.7 | Endogenous pain modulation |
| 1.8 | Receptors |
| 1.9 | Ion channels |
| 1.10 | Tolerance and addiction |
| 1.11 | Anticonvulsants |
| 1.12 | Antidepressants |
| 1.13 | Biologics /peptides |
| 1.14 | Cannabinoids |
| 1.15 | Local anaesthetics |
| 1.16 | NSAIDs, COXIBs, acetaminophen |
| 1.17 | Opioids |
| 1.18 | Imaging – animals |
| 1.19 | Imaging – humans |
| 1.20 | Animal pain models |
| 1.21 | Human pain models |
| 1.22 | Itch |
| 1.23 | Interoception |
| 1.24 | Proprioception |
| 2 |
Clinical pain states |
| 2.1 | Joint, bone, and muscle pain |
| 2.2 | Arthritis |
| 2.3 | Neck and back pain |
| 2.4 | Fibromyalgia |
| 2.5 | Complex regional pain syndromes |
| 2.6 | Headache (Migraine) |
| 2.7 | Headache (Tension type) |
| 2.8 | Headache (Other) |
| 2.9 | Orofacial pain |
| 2.10 | Neuropathic pain |
| 2.11 | Amputation pain |
| 2.12 | Visceral pain |
| 2.13 | Pain and dementia |
| 2.14 | Pain in children |
| 2.15 | Pain in the elderly |
| 2.16 | Pain and gender |
| 2.17 | Perioperative pain |
| 2.18 | Procedural pain |
| 2.19 | Acute pain |
| 2.20 | Cancer pain |
| 2.21 | Pain in Cancer survivors |
| 2.22 | AN other |
|
3 |
Human behavioural science |
| 3.1 | Affective modulation |
| 3.2 | Perception and psychophysics |
| 3.3 | Cognitive processes |
| 3.4 | Learning processes |
| 3.5 | Motivational processes |
| 3.6 | Placebo and expectation |
| 3.7 | Self and identity |
| 3.8 | Social cognition |
| 3.9 | Endurance-avoidance |
| 3.10 | Occupational, school, and work context |
| 3.11 | Patient health-care provider communication |
| 3.12 | Pain behaviour |
| 4 |
Pain treatment (conservative) |
| 4.1 | Acute pain / perioperative pain – Opioids |
| 4.2 | Acute pain / perioperative pain – Other |
| 4.3 | Cancer pain – Opioids |
| 4.4 | Cancer pain – Other |
| 4.5 | Pain in cancer survivors |
| 4.6 | Neuropathic pain |
| 4.7 | Visceral pain |
| 4.8 | Headaches |
| 4.9 | Palliative Care |
| 4.10 | Anticonvulsants |
| 4.11 | Antidepressants |
| 4.12 | Cannabinoids |
| 4.13 | NSAIDs, COX2 inhibitors and acetaminophen |
| 4.14 | Opioids |
| 4.15 | Novel therapeutic agents |
| 4.16 | Topical analgesics |
| 4.17 | Preemptive analgesia |
| 4.18 | Complementary and alternative medicine |
| 4.19 | Physiotherapy |
| 4.20 | Rehabilitation |
| 4.21 | Placebo |
| 5 |
Pain treatment (invasive) |
| 5.1 | Neuromodulation spinal, brain, peripheral |
| 5.2 | Nerve blocks |
| 5.3 | Indwelling catheters |
| 5.4 | Epidurals, translaminar, transforaminal |
| 5.5 | Radiofrequency blocks |
| 5.6 | Spinal analgesia |
| 5.7 | Sympathetic blocks |
| 6 |
Pain treatment (psychological) |
| 6.1 | Cognitive-behavioural treatment |
| 6.2 | Autonomic training |
| 6.3 | Hypnosis |
| 6.4 | Interpersonal therapy |
| 6.5 | Exposure-based treatments |
| 6.6 | Mindfulness, ACT, DBT |
| 6.7 | Partner assisted treatment |
| 6.8 | Family assisted treatment |
| 6.9 | ehealth and mhealth delivery |
| 6.10 | Education and information |
| 7 |
Multidisciplinary pain treatments |
| 8 |
Epidemiology, assessment, organisation of pain treatment |
| 8.1 | Epidemiology |
| 8.2 | Assessment (Quantitative Sensory Testing) |
| 8.3 | Assessment (Patient Reported Outcomes) |
| 8.4 | Assessment (Other) |
| 8.5 | Documentation |
| 8.6 | Systematic Reviews |
| 8.7 | Acute pain services |
| 9 |
Ethics, education, history, law |
| 9.1 | Ethics – animal research |
| 9.2 | Ethics – clinical practice |
| 9.3 | Education / Professional |
| 9.4 | Education / Lay |
| 9.5 | Public relations |
| 9.6 | History and philosophy of pain |
| 9.7 | Legal issues related to pain and pain treatment |